Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Final vesting on 21 May 2024 of Conditional Share awards granted on
21 May 2021 under the Smith & Nephew Global Share Plan 2020,
and subsequent sale of shares to cover tax liability
|
Date of Transaction
|
2024 - 05 - 21
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Craig Gaffin
President, Global Orthopaedics
|
PDMR
|
10.1175
|
1,522 (of which 372 were sold and 1,150 were
retained.)
|
N/A Single Transaction
|
Scott Schaffner
(President Sports Medicine)
|
PDMR
|
10.1175
|
1,141 (of which 279 were sold and 862 retained.)
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting on 20 May 2024 of Conditional Share awards granted
on 12 August 2022 under the Smith & Nephew Global Share Plan
2020, and subsequent sale of shares to cover tax
liability
|
Date of Transaction
|
2024 - 05 - 20
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
10.290135
|
10,088 (of which 4,010 were sold and 6,078 were
retained.)
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting on 20 May 2024 of Conditional Share awards granted
on 19 May 2023 under the Smith & Nephew Global Share Plan 2020,
and subsequent sale of shares to cover tax liability
|
Date of Transaction
|
2024 - 05 - 20
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Craig Gaffin
President, Global Orthopaedics
|
PDMR
|
10.290135
|
1,551 (of which 379 were sold and 1,172 were
retained.)
|
N/A Single Transaction
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
May 22, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|